Through the Microscope: Examining Modern Medicine

February 21, 2017
Boston

Medical breakthroughs, including new drug therapies and health technologies, have accelerated in recent years to transform patient care, turning formerly fatal diseases into chronic ones. These innovations are treating some of the rarest diseases and are bringing new tools to doctors and care providers.

The Atlantic explored the state of modern medicine and the science that has revolutionized treatments. We examined the role of personalized medicine and how new treatments can be made accessible to patients.


Watch full session videos

To view photos from this event, please visit our Facebook page

For more information, please contact Grace Harvey at gharvey@theatlantic.com

Presented by

Atlantic Live

Speakers

  • Laurie Glimcher, MD
    Laurie Glimcher, MD President and CEO Dana-Farber Cancer Institute
  • Stephen J. Ubl
    Stephen J. Ubl President and CEO Pharmaceutical Research and Manufacturers of America
  • Tony Coles, MD
    Tony Coles, MD Chairman and CEO Yumanity Therapeutics
  • Gilmore O'Neill, MD
    Gilmore O'Neill, MD Senior Vice President, Late Stage Clinical Development Biogen Inc.
  • Noubar Afeyan, PhD
    Noubar Afeyan, PhD Founder, CEO and Senior Managing Partner Flagship Pioneering
  • Stephen Elledge, PhD
    Stephen Elledge, PhD Gregor Mendel Professor of Genetics and Medicine Harvard Medical School and the Division of Genetics at Brigham & Women’s Hospital
  • Dan Skovronsky, MD, PhD
    Dan Skovronsky, MD, PhD Senior Vice President, Clinical and Product Development Eli Lilly and Company
  • Joie Chen
    Joie Chen Contributor AtlanticLIVE
  • Ross Andersen
    Ross Andersen The Atlantic Senior Editor
  • Robert Green, MD, MPH
    Robert Green, MD, MPH Associate Physician, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School and Director, Genomes2People Research Program
  • Lauren Stetson
    Lauren Stetson Participant of BabySeq Project
  • Joe Shortsleeve
    Joe Shortsleeve Former Chief Correspondent for WBZ-TV, Current Senior Advisor at Liberty Square
  • Julie Wolf-Rodda
    Julie Wolf-Rodda Director of Development Foundation for the National Institutes of Health

Agenda

  • Tuesday, February 21
  • 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:35 a.m.The DNA of Modern MedicineLaurie Glimcher, President and CEO, Dana-Farber Cancer Institute
    With Joie Chen, Contributor, AtlanticLIVE
  • 8:55 a.m.On the Frontlines of ScienceStephen Elledge, Gregor Mendel Professor of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women’s Hospital
    Julie Wolf-Rodda, Director of Development, Foundation for the National Institutes of Health
    Daniel Skovronsky, Senior Vice President, Clinical and Product Development, Eli Lilly and Company
    With Ross Andersen, Senior Editor, The Atlantic
  • 9:35 a.m.Funding the Future Noubar Afeyan, CEO, Flagship Pioneering
    Tony Coles, CEO, Yumanity Therapeutics
    Gilmore O’Neill, Senior Vice President, Late Stage Clinical Development, Biogen
    With Joie Chen, AtlanticLIVE
  • 10:05 a.m.Making Medicine PersonalRobert Green, Co-Director, BabySeq Project, Brigham and Women’s Hospital and Harvard Medical School
    Lauren Stetson, Participant in BabySeq Project
    With Ross Andersen, The Atlantic
  • 10:35 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE

Underwriter

Also in This Series

Upcoming Events

  • Energy/Sustainability

    The Business of Green: An Atlantic Forum

    The Atlantic will gather leaders from across industry, experts and consumers alike, to explore the way business is employing sustainability to protect the environment.

  • Culture

    Race + Justice: Tucson

    The Atlantic will explore What comes next in creating a more effective and fairer justice system for Tucson and surrounding areas?

  • Culture

    Unfinished Business: The Atlantic's LGBTQ Summit

    The Atlantic will convene policymakers, activists, scholars, legal experts, students and shapers of the national dialogue for a series of conversations on where the LGBTQ movement stands, what its aspirations are and what obstacles lie ahead.